» Articles » PMID: 32104420

Design and Characterization of Monolaurin Loaded Electrospun Shellac Nanofibers with Antimicrobial Activity

Overview
Date 2020 Feb 28
PMID 32104420
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to elucidate the optimized fabrication factors influencing the formation and properties of shellac (SHL) nanofibers loaded with an antimicrobial monolaurin (ML). The main and interaction effects of formulation and process parameters including SHL content (35%-40% w/w), ML content (1%-3% w/w), applied voltage (9-27 kV) and flow rate (0.4-1.2 ml/h) on the characteristic of nanofibers were investigated through a total of 19 experiments based on a full factorial design with three replicated center points. As a result, the SHL content was the major parameter affecting fiber diameter. Another response result revealed that the SHL content would be also the most significant negative impact on amount of beads. An increase in the concentration of SHL leaded to a reduction in the amount of beads. From the results of characterization study, it was proved that ML might be entrapped between the chains of SHL during the electrospinning process exhibiting an excellent encapsulation. According to the response surface area, small (~488 nm) and beadless (~0.48) fibers were obtained with the SHL and ML contents of 37.5% and 1.1% w/w respectively, at the applied voltage of 18 kV and the flow rate of 0.8 ml/h. In addition, the results of the kill-kinetic studies showed that SHL nanofibers loaded with ML exhibited an excellent antibacterial activity against , while was less affected due to the hydrophilic structure of the its outer membrane. ML also exerted an antifungal activity by reducing the number of colonies. Based on their structural and antimicrobial properties, SHL nanofibers containing ML could be potentially used as a medicated dressing for wound treatment.

Citing Articles

Fabrication of Oro-Dispersible Sodium Valproate-Loaded Nanofibrous Patches for Immediate Epileptic Innervation.

Guler E, Yekeler H, Ozdemir Kumral Z, Parviz G, Ozcan G, Uner B ACS Biomater Sci Eng. 2024; 11(3):1523-1538.

PMID: 39707947 PMC: 11897950. DOI: 10.1021/acsbiomaterials.4c02294.


Trends in the Incorporation of Antiseptics into Natural Polymer-Based Nanofibrous Mats.

Pisklakova L, Skuhrovcova K, Bartova T, Seidelmannova J, Vondrovic S, Velebny V Polymers (Basel). 2024; 16(5).

PMID: 38475347 PMC: 10935236. DOI: 10.3390/polym16050664.


Fabrication and Optimization of Electrospun Shellac Fibers Loaded with Leaf Extract.

Aung W, Krongrawa W, Limmatvapirat S, Kulpicheswanich P, Okonogi S, Limmatvapirat C Polymers (Basel). 2024; 16(2).

PMID: 38256981 PMC: 10819501. DOI: 10.3390/polym16020183.


A Novel Comprehensive Therapeutic Approach to the Challenges of Chronic Wounds: A Brief Review and Clinical Experience Report.

Bettle 3rd G, Bell D, Bakewell S Adv Ther. 2023; 41(2):492-508.

PMID: 38104037 PMC: 10838851. DOI: 10.1007/s12325-023-02742-4.


State-of-the-Art Review of Advanced Electrospun Nanofiber Composites for Enhanced Wound Healing.

Abdelhakeem E, Monir S, Teaima M, Rashwan K, El-Nabarawi M AAPS PharmSciTech. 2023; 24(8):246.

PMID: 38030812 DOI: 10.1208/s12249-023-02702-9.


References
1.
Limmatvapirat S, Limmatvapirat C, Luangtana-Anan M, Nunthanid J, Oguchi T, Tozuka Y . Modification of physicochemical and mechanical properties of shellac by partial hydrolysis. Int J Pharm. 2004; 278(1):41-9. DOI: 10.1016/j.ijpharm.2004.02.030. View

2.
Engel E, Michiardi A, Navarro M, Lacroix D, Planell J . Nanotechnology in regenerative medicine: the materials side. Trends Biotechnol. 2007; 26(1):39-47. DOI: 10.1016/j.tibtech.2007.10.005. View

3.
Isaacs C, Litov R, Thormar H . Antimicrobial activity of lipids added to human milk, infant formula, and bovine milk. J Nutr Biochem. 1995; 6(7):362-366. DOI: 10.1016/0955-2863(95)80003-u. View

4.
Candioti L, De Zan M, Camara M, Goicoechea H . Experimental design and multiple response optimization. Using the desirability function in analytical methods development. Talanta. 2014; 124:123-38. DOI: 10.1016/j.talanta.2014.01.034. View

5.
Carpo B, Verallo-Rowell V, Kabara J . Novel antibacterial activity of monolaurin compared with conventional antibiotics against organisms from skin infections: an in vitro study. J Drugs Dermatol. 2007; 6(10):991-8. View